DTaP-IPV vaccine
DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.[1] Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[3] and Quadracel from Sanofi Pasteur.[5][6] In Japan, the formulation is called 四種混合(shishukongou - "mixture of 4").Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').